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Abstract
Background: The aim of this study was to evaluate the role of family history of cancer and personal history of
other medical conditions in the aetiology of the oral cavity cancer in France.
Methods: We used data from 689 cases of oral cavity squamous cell carcinoma and 3481 controls included in a
population-based case–control study, the ICARE study. Odds-ratios (ORs) associated with family history of cancer
and personal medical conditions and their 95% confidence intervals (95% CI) were estimated by unconditional
logistic regression and were adjusted for age, gender, area of residence, education, body mass index, tobacco
smoking and alcohol drinking.
Results: Personal history of oral candidiasis was related to a significantly increased risk of oral cavity cancer (OR 5.0,
95% CI 2.1-12.1). History of head and neck cancers among the first-degree relatives was associated with an OR of
1.9 (95% CI 1.2-2.8). The risk increased with the number of first-degree relatives with head and neck cancer.
Conclusion: A family history of head and neck cancer is a marker of an increased risk of oral cavity cancer and
should be taken into account to target prevention efforts and screening. Further studies are needed to clarify the
association between oral cavity cancer and personal history of candidiasis.
Keywords: Family history, Medical conditions, Oral cavity cancer, Risk factors, Case–control study
Background
Oral cavity cancer (International Classification of Dis-
eases 10th revision (ICD-10) codes C00-C08 [1]) is an
important public health burden with an annual world-
wide incidence estimated at approximately 263,000
cases, and mortality at 127,000 [2]. Among developed
countries, France has the highest age-standardized inci-
dence rate for males (7.6/100,000) and one of the high-
est for females (1.5/100,000) [3]. As is the case for the
other sites of upper aerodigestive tract (UADT), tobacco
and alcohol consumption are the main risk factors for
oral cavity cancer [4,5].
Besides the role of human papilloma viruses (HPV) 16
and 18 in the aetiology of UADT cancers, few other
conditions such as herpetic infection [6-11], candidiasis
[6,10,11], warts [6,9-11], and gastro-oesophageal reflux
[7] have been investigated. The results of the epidemio-
logical studies on the role of these medical conditions in
the occurrence of UADT cancers are contradictory and
the underlying mechanisms are not complete elucidated.
Other risk factors, such as genetic polymorphism in
genes involved in the metabolism of tobacco and alcohol
carcinogens and DNA repair seems to play a role in the
development of UADT cancers [12-19]. Few epidemio-
logical studies considered the risk of UADT cancers in
relatives of subjects with cancer history [20-26]. Familial
clustering of UADT cancers may indicate that genetic
factors play a role in the process of carcinogenesis, but
may also reflect a tendency of relatives to have similar
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behaviour towards tobacco and alcohol. Limited data are
available on the combined effect of family history, and
tobacco and alcohol consumption [20,23,26]. The litera-
ture is contrasted about whether the cancer risk varies
according to UADT subsite, gender, type of affected rela-
tive (parents, siblings), and their cancer site.
The present work aimed to investigate the role of fam-
ily history of cancer and personal medical history in the
aetiology of oral cavity cancer in France using data from
a large case–control study, the ICARE study.
Methods
ICARE study
The ICARE study (Investigation of occupational and en-
vironmental CAuses of REspiratory cancers) is a multi-
centre population-based case–control study on lung and
upper aerodigestive tract cancers carried out from 2001
to 2007 in 10 French administrative areas (“départements”)
covered by a general cancer registry. This study was set up
to explore the role of lifestyle, environmental and occupa-
tional risk factors in lung and UADT cancers. The study
design has been described in details elsewhere [27].
Briefly, all newly diagnosed primary oral cavity, phar-
ynx, larynx, sinusal cavities, trachea and lung cancers
were selected. Only histologically confirmed cases aged
75 or younger at interview, identified between 2001 and
2007, and residing in one of the 10 départements, were
eligible. Clinical and anatomo-pathology reports were
reviewed to determine topography and histological type
of the tumours according to the International Classifica-
tion of Diseases for Oncology [28]. All histological types
were included.
Controls were selected from the general population by
random digit dialling [29]. The controls were frequency-
matched to the cases by age, gender and area of residence
(“département”). Additional stratification ensured that con-
trols were representative of the population of the “départe-
ment” in terms of socio-economic status based on the last
job held.
Present analysis
The present analysis included all ICARE controls and
only the cases with oral cavity cancer (ICD-10 codes
C01-C06).
Among the 1316 oral cavity cancer cases identified as
eligible, 196 could not be reached, 81 were deceased and
71 were too sick to be interviewed. Of the 968 cases
who were contacted, 176 refused to participate and 792
(81.8%) answered the questionnaire. We focused only on
the cases with squamous cell carcinoma (772 subjects,
97.5% of all cases with oral cavity cancer).
Of 4673 eligible controls, 4411 were contacted, and
3555 (80.6%) agreed to participate.
Data collection
Trained interviewers administered a detailed standar-
dised questionnaire during face-to-face interviews. If the
subject was too sick to be interviewed, a shortened ver-
sion of the questionnaire was used to interview him or a
next-of-kin. Among the 772 subjects with squamous cell
carcinoma of the oral cavity, 689 (89.2%) filled a complete
questionnaire and 83 (10.8%) a shortened questionnaire.
Among controls, 3481 (97.9%) filled a complete question-
naire and 74 a shortened questionnaire (2.1%). As the
shortened version of the questionnaire did not contain in-
formation about family history of cancer and medical con-
ditions, the present analysis was based on 689 cases with
squamous cell carcinoma and 3481 controls, all with a
complete questionnaire.
The complete questionnaire consisted of the following
items: socio-demographic characteristics (age, gender,
birth country, education level, marital status), residential
history, personal medical history, family history of can-
cer, detailed tobacco and alcohol consumption (quantity,
duration, type of product, age at starting, time since
cessation), non-alcoholic beverage consumption (coffee,
tea), anthropometric variables (height, weight at inter-
view, two years before and at age 30), detailed lifelong
job history and occupational exposures.
To ascertain personal medical history, study partici-
pants were asked if, throughout their lives, they had ever
had (“yes, no, or don’t know”) any of the following dis-
eases: tuberculosis, chronic bronchitis, asthma, recurrent
rhinitis, nasal polyps, recurrent nose bleeds, recurrent si-
nusitis, gastro-oesophageal reflux (heartburn or regurgi-
tation), herpes, candidiasis, and warts. If the answer was
“yes”, the subjects were asked to specify the age at first
occurrence, the treatment and if the diagnosis was made
by a doctor. Subjects reporting having ever had herpes,
candidiasis or warts were asked to specify the location:
lip and genitals for herpes, oral cavity and genitals for can-
didiasis, and hands, feet and head and neck for warts.
To ascertain the family history of cancer, subjects were
first asked to give the year of birth of their biological
mother and father, and of their full brothers or sisters
(“brother or sister having the same mother and the same
father than you”). Then, they were asked for each of
these relatives if she/he had ever had a cancer (“yes, no
or don’t know”). If the answer was “yes”, the subjects
were asked to specify the age at cancer diagnosis and if
possible the type of cancer. No verification of the cancer
diagnosis in the relatives was performed.
Statistical analysis
We used unconditional logistic regression models to cal-
culate odds ratios (OR) and their 95% confidence inter-
vals (95% CI). All p-values were derived from two-sided
statistical tests.
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All logistic regression models controlled for age (≤ 50,
51–59, 60–69, ≥ 70 years), gender, area of residence,
education level (primary or less, vocational secondary,
general secondary and university), BMI two years before
the interview (categorical, according to the classification
of the World Health Organization [30]: < 18.5, 18.5-24.9,
25.0-29.9, ≥ 30 kg/m2). Previous analyses of our data
showed that the variables that best characterize the associ-
ation between tobacco and alcohol consumption and oral
cancer risk were smoking status, smoking duration, daily
quantity of tobacco smoked and daily quantity of alcohol
drinking [31]. To control for smoking, we used smoking
status (never, current, former), average daily quantity of
tobacco smoked (1–19, 20–39, ≥ 40 grams), and duration
of smoking (1–30, 31–40, > 40 years) [32]. Average daily
quantity of alcohol drinking in quartiles (never, < 0.6, 0.6-
2.0, 2.1-4.5, > 4.5 standard glasses) was included in the
models to adjust for alcohol drinking. The quantity of
pure alcohol contained in a standard glass (15 cl of wine,
30 cl of beer, 5 cl of spirits, 10 cl of aperitif, and 30 cl of
cider) is the same for each type of alcoholic beverage.
We analysed the risk of oral cavity cancer related to
the personal medical history using two variables: all
medical conditions self-reported by the subjects and
medical conditions reportedly diagnosed by a doctor.
The date of interview was used as the date of reference
for both cases and controls. This date was close to the
date of diagnosis of the cases since cases were inter-
viewed on average within three months of diagnosis.
The family history of cancer was evaluated separately
for mothers, fathers, brothers and sisters, and then
among all first-degree relatives taken together. We ana-
lysed the risk of oral cavity cancer related to the cancer
site among relatives: all sites together, head and neck
(including oral cavity, pharynx, larynx, nasal cavity and
sinuses) and non-head and neck cancers. Because a high
number of cancers in family members were reported
non-specifically as “cancer of the head and neck”, we
chose to group the locations of head and neck cancers
to reduce potential inaccurate reporting of cancer sub-
sites. We nevertheless performed some analyses for fam-
ily history of specific head and neck cancer sites among
all first-degree relatives.
We also conducted analyses stratified by tobacco and
alcohol consumption. We also performed the same ana-
lyses using a more restricted definition of the oral cavity
excluding base of tongue (C01), lingual tonsils (C02.4),
soft palate (C05.1) and uvula (C05.2), since these sub-
sites are often included in the oropharynx. In addition,
seven subsites (base of the tongue, mobile tongue, floor
of the mouth, gums, soft palate, hard palate, and other
parts of the oral cavity) were compared for family history
of cancer and personal history of other medical condi-
tions using unconditional polytomous logistic regression.
Statistical analyses were conducted using STATA soft-
ware version 10.0 (StataCorp, Texas, USA).
Results
Among the 689 cases, the most common tumour location
was floor of the mouth (188 cases, 27.3%), followed by
mobile tongue (162 cases, 23.5%) and base of the tongue
(130 cases, 18.9%). Less frequent tumour locations were:
other parts of the oral cavity (81 cases, 11.7%), soft palate
(74 cases, 10.7%), gums (37 cases, 5.4%), and hard palate
(17 cases, 2.5%). The analysis using the restricted defin-
ition of oral cavity involved 485 cases.
The main characteristics of cases and controls are pre-
sented in Table 1.
Men represented more than two-thirds of subjects in
both cases and controls. Cases were younger (mean age
around 57 years) than controls (mean age around 59 years)
(p < 0.001).
Compared with controls, cases had a lower education
level (p < 0.001), a higher consumption of tobacco (p <
0.001) and alcohol (p < 0.001), and a lower BMI two
years before the interview (p < 0.001).
Personal medical conditions
Statistical analysis showed significant positive associa-
tions between the risk of oral cavity cancer (C01-C06)
and chronic bronchitis (OR 1.7, 95% CI 1.2-2.4) (Table 2).
Histories of tuberculosis and candidiasis overall were as-
sociated with an increased risk of oral cavity cancer
(ORs 1.6), but the results did not reach statistical signifi-
cance. Among candidiasis locations, oral candidiasis was
associated with an increased risk of oral cavity cancer
(OR 5.0, 95% CI 2.1-12.1). Significant inverse relations
were observed between the risk of oral cavity cancer and
recurrent rhinitis (OR 0.6, 95% CI 0.4-0.9), nasal polyps
(OR 0.3, 95% CI 0.1-0.9), and gastro-oesophageal reflux
(OR 0.5, 95% CI 0.4-0.7). Herpetic lesions were not re-
lated to the risk of oral cavity cancer, regardless of the
location of the herpes. The risks associated with a his-
tory of skin warts were reduced, but the results did not
reach statistical significance.
Because high prevalence of oropharyngeal candidiasis
has been described in subjects with head and neck can-
cer undergoing radio/chemotherapy [33,34], we also
conducted analysis after excluding subjects declaring
candidiasis at the time of interview or at the time of
diagnosis of another cancer; the association between oral
cavity cancer risk and oral candidiasis remained practically
unchanged (OR 6.0, 95% CI 2.2-16.4). Oral candidiasis
may also constitute an early manifestation of the cancer-
ous disease. When we excluded all subjects reporting a
history of oral candidiasis near the current cancer (up to
two years before the cancer diagnosis), the association
Radoï et al. BMC Cancer 2013, 13:560 Page 3 of 10
http://www.biomedcentral.com/1471-2407/13/560
between oral cavity cancer and oral candidiasis remained
significant (OR 3.7, CI 95% 1.3-10.1).
We calculated the ORs for oral candidiasis in strata of
tobacco and alcohol consumption. The OR was slightly
higher in ever smokers (OR 5.6, 95% CI 2.0-15.2) than in
never smokers (OR 4.3, 95% CI 0.5-41.7), but the inter-
action between tobacco smoking and oral candidiasis
was not significant (p-value for interaction = 0.14). Oral
candidiasis was associated with an elevated risk of oral
cavity cancer in drinkers of more than 2 glasses/day (OR
3.9, 95% CI 1.0-14.8) but not in drinkers of 2 glasses/day
or less (OR 1.1, 95% CI 0.2-23.8), although the ORs were
not statistically different (p-value for interaction = 0.50).
When the analysis was restricted to medical conditions
that the subjects reported as diagnosed by a doctor, simi-
lar results were observed, except for the association
between bronchitis and oral cavity cancer which became
weaker and non-significant (OR 1.2, 95% CI 0.9-1.6)
(data not shown).
Family history of cancer
The associations between family history of cancer and
risk of oral cavity cancer are presented in Table 3.
History of cancer in general, and of head and neck
cancer in particular, among fathers, were associated with
a slightly elevated risk of oral cavity cancer, but the
results were not statistically significant (OR 1.3, 95% CI
0.9-1.6, and 1.5, 95% CI 0.9-2.4, respectively).
History of head and neck cancer among mothers was
significantly associated with an elevated risk of oral cav-
ity cancer (OR 5.2, 95% CI 1.2-23.9). This OR was higher
than that observed for fathers. When cancer history
among siblings was analysed, after adjustment for the
number of sisters and brothers, we observed a signifi-
cant association between the risk of oral cavity cancer
and history of cancer of any type (OR 1.4, 95% CI 1.1-
1.9). History of head and neck cancer among siblings
Table 1 Main characteristics of cases and controls
Cases Controls p*
N (%) N (%)
Gender p = 0.12
Male 556 (80.7) 2720 (78.1)




Calvados 65 (9.4) 458 (13.1)
Doubs/Territoire de Belfort 9 (1.3) 134 (3.8)
Hérault 71 (10.3) 437 (12.5)
Isère 82 (11.9) 497 (14.3)
Loire Atlantique 127 (18.4) 404 (11.6)
Manche 68 (9.9) 311 (8.9)
Bas Rhin 62 (9.0) 451 (12.9)
Haut Rhin 14 (2.0) 118 (3.4)
Somme 145 (21.0) 476 (13.7)
Vendée 46 (6.8) 195 (5.8)
Age at interview p < 0.001
< 50 161 (23.4) 807 (23.2)
50-59 293 (42.5) 995 (28.6)
60-69 171 (24.8) 1160 (33.3)
≥ 70 64 (9.3) 519 (14.9)
Education level p < 0.001
Primary or less 227 (32.9) 763 (21.9)
Vocational secondary 294 (42.7) 1351 (38.8)
General secondary 60 (8.7) 400 (11.5)
University 85 (12.3) 901 (25.9)
Tobacco status p < 0.001
Never-smokers 53 (7.7) 1233 (35.4)
Former smokers† 152 (22.1) 1436 (41.2)




Never-smokers 53 (7.7) 1233 (35.4)
1-19 275 (39.9) 1486 (42.7)
20-39 271 (39.3) 600 (17.2)




Never-smokers 53 (7.7) 1233 (35.4)
1-30 179 (26.0) 1454 (41.8)
31-40 284 (41.2) 468 (13.4)




Never-drinkers 38 (5.5) 298 (8.6)
Table 1 Main characteristics of cases and controls
(Continued)
< 0.6 60 (8.7) 908 (26.1)
0.6-2.0 74 (10.7) 914 (26.2)
2.1-4.5 140 (20.3) 771 (22.1)
> 4.5 360 (52.2) 570 (14.8)
BMI 2 years before the
interview
p < 0.001
< 18.5 28 (4.1) 38 (1.1)
18.5-24.9 380 (55.2) 1367 (39.3)
25-29.9 188 (27.3) 1367 (39.3)
≥ 30 65 (9.4) 577 (16.6)
*p values are derived from the Pearson’s chi-square test for categorical vari-
ables or Student’s tests for continuous variables.
†Former smokers were subjects who had stopped smoking for at least 2 years.
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Table 2 Risks of oral cavity cancer associated with
personal medical conditions






Never 650 3228 1 (reference)
Ever 29 136 1.6 (0.9-2.5)
Chronic bronchitis
Never 571 3032 1 (reference)
Ever 105 343 1.7 (1.2-2.4)
Asthma
Never 632 3090 1 (reference)
Ever 48 284 1.1 (0.7-1.7)
Recurrent rhinitis
Never 623 2843 1 (reference)
Ever 53 519 0.6 (0.4-0.9)
Recurrent nose bleeds
Never 632 3043 1 (reference)
Ever 45 327 0.9 (0.6-1.4)
Nasal polyps
Never 672 3251 1 (reference)
Ever 5 113 0.3 (0.1-0.9)
Recurrent sinusitis
Never 590 2796 1 (reference)
Ever 88 578 0.7 (0.5-1.0)
Gastro-oesophageal reflux
Never 591 2612 1 (reference)
Ever 85 753 0.5 (0.4-0.7)
Herpetic lesions
Never 625 2964 1 (reference)
Ever‡ 49 400 0.9 (0.6-1.4)
Lip 41 347 0.8 (0.5-1.2)
Genitals 4 34 1.2 (0.4-3.9)
Candidiasis
Never 645 3224 1 (reference)
Ever‡ 28 136 1.6 (0.9-2.8)
Oral cavity 14 80 5.0 (2.1-12.1)
Genitals 6 47 1.0 (0.3-2.7)
Skin warts
Never 461 1909 1 (reference)
Ever§ 215 1458 0.8 (0.6-1.1)
Hands 170 1101 0.8 (0.6-1.0)
Feet 39 327 0.7 (0.5-1.2)
Head and neck 8 111 0.5 (0.2-1.3)
*OR adjusted for age, gender, area of residence, education level, tobacco
smoking (duration, quantity and status), alcohol drinking (quantity) and BMI
two years before the interview.
‡Location of herpetic lesions and candidiasis not reported by 24 subjects and
17 subjects, respectively.
§Multiple locations reported by 83 subjects.
Table 3 Risks of oral cavity cancer associated with family





OR (95% CI)†, ‡
Family history of cancer (father)
All type of cancer
Never 430 2503 1 (reference)
Ever 185 796 †1.3 (0.9-1.6)
Head and neck cancer
Never 576 3200 1 (reference)
Ever 39 99 †1.5 (0.9-2.4)
Family history of cancer (mother)
All type of cancer
Never 543 2784 1 (reference)
Ever 97 603 †0.9 (0.6-1.2)
Head and neck cancer
Never 633 3378 1 (reference)
Ever 7 9 †5.2 (1.2-23.9)
Family history of cancer (brothers)
All type of cancer
Never 229 1218 1 (reference)
Ever 77 288 ‡1.4 (0.9-2.1)
Head and neck cancer
Never 286 1467 1 (reference)
Ever 20 39 ‡2.6 (1.2-5.8)
Family history of cancer (sisters)
All type of cancer
Never 190 1236 1 (reference)
Ever 72 309 ‡1.4 (0.9-2.1)
Head and neck cancer
Never 251 1517 1 (reference)
Ever 11 28 ‡1.7 (0.6-4.2)
Family history of cancer
(any first-degree relative)
All type of cancer
Never 250 1567 1 (reference)
Ever 333 1595 †1.2 (0.9-1.5)
1-2 329 1552 1.0 (0.8-1.3)
≥3 4 43 1.5 (1.0-2.1)
Head and neck cancer
Never 462 2784 1 (reference)
Ever 68 157 †1.9 (1.2-2.8)
1-2 64 150 1.7 (1.1-2.6)
≥3 4 7 7.2 (1.3-40.1)
†OR adjusted for age, gender, area of residence, education level, tobacco
smoking (duration, quantity and status), alcohol drinking (quantity) and BMI
two years before the interview.
‡OR adjusted, in addition to the variables of the first model, for the number of
brothers, sisters or siblings, respectively.
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was associated with an increased risk of oral cavity can-
cer (OR 2.3, 95% CI 1.2-4.2). Analysis by type of sibling
showed a significantly increased risk only among sub-
jects having brothers with a history of head and neck
cancer (OR 2.6, 95% CI 1.2-5.8); history of head and
neck cancer among sisters was not significantly associ-
ated with an increased risk of oral cavity cancer (OR 1.7,
95% CI 0.6-4.2).
When we analysed the relationship between cancer
history among all first-degree relatives and oral cavity
cancer risk, we observed significant association for his-
tory of head and neck cancer (OR 1.9, 95% CI 1.2-2.8).
A family history of any type of cancer slightly increased
the risk of oral cavity cancer, but the results were not
statistically significant (OR 1.2, 95% CI 0.9-1.5). The risk
associated with first-degree relatives’ history of cancer
(any type and head and neck) increased with the number
of affected relatives.
Analysis by type of head and neck cancer in first-degree
relatives showed significantly increased risks of oral cavity
cancer in subjects with family history of oral cavity cancer
(OR 3.5, 95% CI 1.1-11.2) and of “head and neck cancer”
(not specified) (OR 1.8, 95% CI 1.1-2.9). A family history
of pharyngeal, laryngeal, and sinonasal cancer was associ-
ated with non-significantly elevated risks of oral cavity
cancer (OR 4.6, 95% CI 0.5-44.8 for history of pharyngeal
cancer; 1.6, 95% CI 0.6-4.4 for history of laryngeal cancer;
and 1.7, 95% CI 0.3-8.8 for history of sinonasal cancer).
However, few subjects reported a specific location of head
and neck cancer in first degree relatives (26 oral cavity, 5
pharynx, 35 larynx, and 11 nasal cavity/sinuses cancer).
Analysis stratified by gender of first-degree relatives
showed that history of head and neck cancer among fe-
male relatives (mothers and sisters) was not significantly
associated with the risk of oral cavity cancer (OR 2.3,
95% CI 0.9-5.4), although the result was borderline sig-
nificant. Conversely, history of head and neck cancer in
male relatives (fathers and brothers) was significantly as-
sociated with the risk of oral cavity cancer (OR 1.9, 95%
CI 1.2-3.3). However, these ORs did not differ signifi-
cantly (p-value of test of comparison of ORs = 0.91).
We found a stronger association between the risk of
oral cavity cancer and family history of head and neck
cancer in subjects aged 45 or more (OR 2.3, 95% CI 1.5-
3.4) compared to subjects aged less than 45 (OR 1.3,
95% CI 0.3-6.7), although the ORs were not statistically
different (p-value for interaction = 0.46).
Analysis by cancer site among first-degree relatives
(Table 4) showed elevated ORs among subjects having a
family history of lung, oesophagus, cervix and corpus
uteri, brain and nervous system cancer, but the results
were not statistically significant (OR 1.4, 95% CI 0.9-1.9;
1.5, 95% CI 0.7-3.3; 1.7, 95% CI 0.9-3.1; 2.0, 95% CI 0.9-
4.8 respectively).
When we stratified by tobacco smoking and/or alcohol
drinking (Table 5), significantly increased risks of oral
cavity cancer related to family history of any type of can-
cer were observed only in smokers and/or moderate to
heavy drinkers. Significantly elevated risks of oral cavity
cancer associated with family history of head and neck
cancer were seen for both never and ever smokers and
for light and moderate to heavy drinkers. However, the
increase in risk was small and not significant for never
smokers who were also light drinkers.
Analyses restricted to intraoral cavity
When the analyses were limited to intraoral cavity (C02.0-
C02.3, C02.8, C02.9, C03, C04, C05.0, C05.8, C05.9, C06),
the results were similar to that observed for oral cavity
globally (C01-C06). Thus, family history of UADT cancer
among first-degree relatives was associated with an OR of
1.7 (95% CI 1.1-2.7), personal history of oral candidiasis
with an OR of 4.9 (95% CI 1.8-13.3), gastro-oesophageal
reflux with an OR of 0.6 (95% CI 0.4-0.8), recurrent rhin-
itis with an OR of 0.6 (95% CI 0.4-0.9), and nasal polyps
with an OR of 0.3 (95% CI 0.1-0.9).
Table 4 Odds ratios for oral cavity cancer risk related to
family history of selected cancers in first-degree relatives
Subjects with family history (any
first-degree relative)
Cancer site Cases Controls OR (95% CI)†
Lung 71 248 1.4 (0.9-1.9)
Oesophagus 12 51 1.5 (0.7-3.3)
Stomach 14 89 0.9 (0.-1.8)
Intestines 37 274 0.8 (0.5-1.3)
Liver 18 95 1.1 (0.6-2.1)
Pancreas 8 55 0.7 (0.3-1.8)
Thyroid gland 3 15 0.8 (0.2-3.2)
Bones and cartilages 10 43 1.1 (0.4-2.6)
Skin 5 65 0.3 (0.1-1.1)
Prostate 27 172 1.2 (0.7-1.9)
Other male genital tract 2 11 1.2 (0.2-7.4)
Breast 56 312 1.0 (0.7-1.5)
Cervix and corpus uteri 21 108 1.7 (0.9-3.1)
Other female genital tract 3 28 0.4 (0.2-2.2)
Bladder 4 39 0.7 (0.3-2.2)
Other urinary tract 8 55 0.6 (0.2-1.7)
Brain and nervous system 16 49 2.0 (0.9-4.8)
Lymphoma, leukaemia 18 122 1.1 (0.6-2.1)
Other and unspecified sites 9 40 1.0 (0.3-2.8)
†ORs adjusted for age, gender, area of residence, education level, tobacco
smoking (duration, quantity and status), alcohol drinking (quantity) and BMI
two years before the interview.
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Analyses by subsite
We assessed the risk of oral cavity cancer by anatomical
site of the oral cavity (base of tongue, mobile tongue,
gum, floor of mouth, hard and soft palate, and other
parts of oral cavity) for personal medical conditions and
for family history of cancer using a polytomous regres-
sion. We did not find any difference between subsites
for any variable of interest (tests of comparison of odds
ratios non-significant) (data not shown).
Discussion
To our knowledge, the ICARE study is the first
population-based case–control study in France and one
of the largest in the world which investigates the role of
risk factors other than tobacco and alcohol consumption
in the occurrence of oral cavity cancer. Strengths of this
study include large sample size allowing us to perform
analyses by subsite, and detailed data about family his-
tory of cancer and personal medical history.
The ICARE study was conducted in collaboration with
the cancer registries, allowing us to recruit cancer cases in
all healthcare establishments in the selected areas. The
control group was population-based and common for both
pathologies (lung and UADT cancers), which explains the
significantly different distribution of age and area of resi-
dence between oral cavity cancer cases and controls. How-
ever, the large number of subjects in each category allowed
for satisfactory adjustment for these variables.
The results of the epidemiological studies are contrasted
concerning the role of candidiasis in the occurrence of
oral cavity cancer, Thus, history of oral candidiasis was as-
sociated with an increased risk of oral cavity and oropha-
ryngeal cancer in one study [11], with a reduced risk of
oral cavity cancer in another study [7], whereas other au-
thors found no association [6]. Our results have shown
that personal history of oral candidiasis was associated
with an elevated risk of oral cavity cancer. The increase in
cancer risk with oral candidiasis may be explained by the
production of endogenous nitrosamines by Candida albi-
cans [35]. These nitrosamines act on the normal epithe-
lium leading to oral dysplasia and further development of
oral carcinoma. Nevertheless, some authors suggested that
Candida albicans have only an indirect role and that the
possibility of their involvement exist in conjunction with
other etiological factors such as tobacco smoking [36]. In
our study, the risk of oral cavity cancer associated with
history of candidiasis was slightly higher in smokers than
in never smokers, but the ORs were not significantly dif-
ferent. Other studies showed that Candida albicans may
metabolize ethanol into its carcinogenic metabolite, acet-
aldehyde and, accordingly, candidiasis may be associated
with elevated acetaldehyde levels in the oral cavity [37,38].
Consistent with this mechanism, we found a significantly
elevated risk of oral cavity cancer associated with history
of candidiasis in moderate to heavy drinkers but not in
light drinkers. However, the interaction of oral candidiasis
with alcohol drinking was not statistically significant. Also,
chronic infections, specifically chronic hyperplastic can-
didiasis, may trigger cell proliferation, inhibit apoptosis,
interfere with cellular signalling mechanisms and up-
Table 5 Risks of oral cavity cancer related to family history of cancer in first-degree relatives stratified by tobacco
smoking and alcohol drinking
Any first-degree relative
History of cancer (any site) History of head and neck cancer
‡No Yes OR (95% CI)† §No Yes OR (95% CI)†
Cases/controls Cases/controls Cases/controls Cases/controls
Smoking
Never 19/563 27/559 1.1 (0.6-2.1) 35/994 6/51 2.4 (1.0-7.0)
Ever 231/1002 306/1030 1.3 (1.1-1.5) 427/1785 58/104 2.7 (1.8-3.4)
Drinking
≤2 glasses/day 75/961 75/954 0.9 (0.6-1.4) 123/1704 11/88 1.9 (1.0-3.5)
>2 glasses/day 167/597 254/631 1.4 (1.0-1.8) 329/1066 52/67 2.6 (1.2-3.3)
Smoking & drinking
NS & D ≤2 glasses/day 16/412 17/425 0.9 (0.4-1.9) 30/740 1/39 1.2 (0.3-4.7)
ES & D ≤2 glasses/day 59/548 58/526 0.9 (0.6-1.4) 93/962 10/47 1.6 (1.0-3.9)
NS & D >2 glasses/day 3/147 8/129 2.7 (0.6-11.6) 5/248 4/10 18.8 (2.9-119.8)
ES & D >2 glasses/day 164/449 246/499 1.4 (1.0-1.8) 324/815 48/57 2.1 (1.3-2.9)
†OR adjusted for age, gender, area of residence, education level, tobacco smoking (duration, quantity and status), alcohol drinking (quantity) and BMI two years
before the interview.
NS = never smoking; ES = ever smoking; D = drinking.
‡Reference category: no history of cancer (any site) in first-degree relatives.
§Reference category: no history of head and neck cancer in first-degree relatives.
Radoï et al. BMC Cancer 2013, 13:560 Page 7 of 10
http://www.biomedcentral.com/1471-2407/13/560
regulate tumour promoters [39,40]. In our study only 14
cases and 80 controls reported prior candidiasis and the
results should be confirmed by other studies, especially
with medical conditions validated by a doctor.
In agreement with previous studies [7,8,11], we did
not find a significant association between the risk of oral
cavity cancer and history of herpetic infection. Conversely,
only one case–control study [10] found an increased risk
of oral cavity and oropharynx cancer associated with this
infection and two case–control studies [6,9] found a de-
creased risk.
Cutaneous warts are caused by different types of HPV,
notably 2, 4, 7 and 57, whereas genital warts are caused
mostly by HPV types 6 and 11 [41]. Three studies [6,8,11],
like ours, did not find any association between history of
warts (any location) and the risk of oral cavity cancer,
whereas one study found a reduced risk of UADT cancer
associated with feet, genital and head and neck warts [7].
We found an inverse association between the oral cav-
ity cancer risk and history of rhinitis and nasal polyps.
These pathologies often have an allergic origin, and sev-
eral studies found a decreased risk of head and neck
cancer associated with a history of allergies [42-45]. The
inverse association between allergies and cancer may be
explained by an overactive immune function in allergic
subjects that effectively detects and eradicates malignant
cells, toxins or pathogens from the body [46,47]. How-
ever, we did not find any association with the history of
asthma, another allergies-related condition.
We found also an inverse association between oral
cavity cancer risk and history of gastro-oesophageal
reflux but we cannot point to any specific mechanism.
The possibility that this result is due to the chance may
not be ruled out. Unlike our results, a recent case–con-
trol study [7] did not find any association between oral
cavity cancer risk and gastro-oesophageal reflux.
After controlling for main confounding factors, we ob-
served a higher risk of oral cavity cancer among subjects
having first-degree relatives with head and neck cancer
history, compared to subjects without such a family his-
tory. The risk increased with the number of affected rel-
atives. On the other hand we did not find a significant
relationship between the risk of oral cavity cancer and
family history of non-head and neck cancers. Several
studies [20,22,23,26] reported similar results.
Early age of onset may be a feature of hereditary forms
of cancer. Higher family risks for many cancers were
found when the cancer subjects were diagnosed at an early
age [48,49]. Concerning the association between the risk
of oral cancer and family history of head and neck cancer,
no clear pattern emerges from epidemiological studies:
some of them found a stronger association in younger
subjects compared to older subjects [20,21,23], others
found a contrary result [22,26], but the differences in risk
with age of onset were never significant. Similarly, in our
study the interaction of family history of head and neck
cancer with age was not significant, although the OR was
somewhat higher in older subjects.
Familial clustering of cancer cases could be explained
by genetic polymorphism in genes involved in the me-
tabolism of tobacco and alcohol carcinogens and DNA
repair [12-19], but may also reflect a tendency of relatives
to have similar behaviour concerning alcohol and tobacco.
In our study, associations between oral cavity cancer
risk and family history of cancer were observed among
smokers and/or drinkers of >2 glasses/day only. Con-
versely, an increased risk of oral cavity cancer associated
with a family history of head and neck cancer was also
observed in non-smokers and light drinkers, but the risk
increased with the exposure. Our results are similar to
those of other studies on oral/pharyngeal or head and
neck cancer [20,23,26].
The differential ability of subjects to metabolize carcino-
gens when exposure to tobacco and/or alcohol occurs
may explain the higher risk of oral cavity cancer observed
in our study among smokers and drinkers having a family
history of UADT cancer. Nevertheless, we did not observe
an increased risk of oral cavity cancer in subjects having a
family history of other cancers related to smoking and/or
alcohol drinking (e.g. lung, oesophagus, liver, pancreas),
suggesting that other genetic factors might explain these
findings.
When the analyses were limited to intraoral cavity
(C02.0-C02.3, C02.8, C02.9, C03, C04, C05.0, C05.8, C05.9,
C06), excluding the sites usually attached to oropharynx
(C01, C02.4, C05.1, C05.2), the results were similar to that
observed for oral cavity C01-C06. We did not find any
difference between subsites base of the tongue, mobile
tongue, gums, floor of the mouth, soft palate, hard palate,
and other parts of the mouth for any variable of interest.
Some limitations of our study can be discussed. The
subjects self-reported their own medical history and
family history of cancer. Thereby, recall bias could not
be ruled out and it is possible that the cases had a higher
motivation to recall their personal and family medical
history than the controls. Nevertheless, two studies have
shown that subjects in case–control studies are able to
report accurately family history of common types of can-
cer among first-degree relatives, with little observable re-
call bias [50,51]. In addition, family history of cancer
sites other than head and neck was not associated with
an increased risk of oral cavity cancer in this study, sug-
gesting that no major recall bias concerning cancer in
general has affected our results.
With regards to oral candidiasis, a possible explanation
would be that cases with oral cancer are more prone to
recall previous oral lesions than controls. However, no
association was found with labial herpes, another oral
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condition, suggesting that differential recall between cases
and controls is unlikely to explain our results. Moreover,
when we limited the medical conditions to those report-
edly diagnosed by a doctor, the results were similar. Med-
ical treatments were also collected and those reported for
candidiasis were consistent with this pathology. So, we
think that misclassification of candidiasis is unlikely to ex-
plain our results.
Information about other known risk factors for oral
cavity cancer such as diet, human papilloma virus (HPV)
or dental health was not collected, and residual con-
founding cannot be excluded. Nevertheless, no associ-
ation between diet, HPV infection or dental health and
family history of cancer has ever been shown in the lit-
erature. Also, the possibility of residual confounding for
the main risk factors may not be ruled out.
We have no way to assess whether cases included in
our study differed according to past medical conditions
and family history of cancer from cases that could not
be included. Nevertheless, the distribution of included
cases by age, gender and cancer subsite was very similar
to that of all oral cancer cases diagnosed in France [52],
suggesting that no major selection bias occurred. We ex-
cluded from analysis all subjects with shortened ques-
tionnaires because information on medical conditions
and family history of cancer was not available. However,
these subjects were comparable in age, gender, and to-
bacco and alcohol consumption to subjects with complete
questionnaires.
Conclusion
This study showed that family history of head and neck
cancer is related to an increased risk of oral cavity can-
cer, and suggested an association with personal history
of oral candidiasis. From a public health point of view,
these factors should be taken into account to target pre-
vention efforts and screening.
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